All terms in DRUGBANK

Label Id Description
OTL-38 DB15413 [OTL-38 is under investigation in clinical trial NCT02769533 (A Phase 1, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Pituitary Adenoma).]
PX-102 DB15416 [PX-102 is under investigation in clinical trial NCT01998672 (Multiple Ascending Oral Dose Phase I Study With Px-102).]
Tomaralimab DB15415 [Tomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).]
(S)-Propafenone DB15410 [(S)-Propafenone is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).]
LB-100 DB15412 [LB-100 is under investigation in clinical trial NCT03886662 (A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)).]
ABP-700 DB15411 [ABP-700 is under investigation in clinical trial NCT02800590 (Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy).]
Hadacidin DB02109
Lysophosphatidylglycerol DB03438
Leucine - Reduced Carbonyl DB02107
2-Aminoethanimidic Acid DB02108
4,6-dideoxy-4-amino-alpha-D-glucose DB03439
5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE DB04769
Pyrithiamine Pyrophosphate DB04768
3,5-Dinitrocatechol DB02105
Gallichrome DB03436
(2R,4S)-2-[(1R)-1-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid DB03437
[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid DB02106
N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID DB04767
3[N-Morpholino]Propane Sulfonic Acid DB03434
2-Chlorodideoxyadenosine DB02103